New inhibitors of protein kinase CK2, analogues of benzimidazole and benzotriazole

Molecular and Cellular Biochemistry

Volumn 316, Issue 1-2, 2008, Pages 87-89

  Bretner, Maria ^a,b   Najda Bernatowicz, Andzelika ^a   Łebska, Maja ^a   Muszyńska, Graüyna ^a   Kilanowicz, Anna ^c   Sapota, Andrzej ^c  

^a INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

^b WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Analogues of 4,5,6,7 tetrabromo 1H benzimidazole; Analogues of 4,5,6,7 tetrabromo 1H benzotriazole; Inhibitors of CK2

Indexed keywords

2 (4,5,6,7 TETRABROMO 1H BENZOTRIAZOL 1 YL)ETHAN 1 OL; 3 (4,5,6,7 TETRABROMO 1H BENZIMIDAZOL 1 YL)PROPAN 1 OL; 3 (4,5,6,7 TETRABROMO 1H BENZOTRIAZOL 1 YL)PROPAN 1 OL; 3 (4,5,6,7 TETRABROMO 2H BENZOTRIAZOL 2 YL)PROPAN 1 OL; 4 (4,5,6,7 TETRABROMO 2H BENZOTRIAZOL 2 YL)BUTAN 1 OL; 4,5,6,7 TETRABROMO 1H BENZIMIDAZOL 2 N,N DIMETHYLAMINE; 4,5,6,7 TETRABROMOBENZIMIDAZOLE; 4,5,6,7 TETRABROMOBENZIMIDAZOLE DERIVATIVE; 4,5,6,7 TETRABROMOBENZOTRIAZOLE; 4,5,6,7 TETRABROMOBENZOTRIAZOLE DERIVATIVE; BENZIMIDAZOLE DERIVATIVE; BENZOTRIAZOLE DERIVATIVE; BK 005; CASEIN KINASE II; CASEIN KINASE II INHIBITOR; MB 001; MB 002; MB 003; PROTEIN SERINE THREONINE KINASE INHIBITOR;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG POTENCY; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; IC 50; NONHUMAN; RAT; SINGLE DRUG DOSE; STRUCTURE ACTIVITY RELATION;

BENZIMIDAZOLES; CASEIN KINASE II; HUMANS; PROTEIN KINASE INHIBITORS; TRIAZOLES;

MAMMALIA;

EID: 50649092883     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9827-0     Document Type: Article

References (14)

1. Wang H, Yu S, Davis AT, Ahmed K (2003) Cell cycle dependent regulation of protein kinase CK2 signaling to the nuclear matrix. J Cell Biochem 88:812-822. doi: 10.1002/jcb.10438
2. Ljubimov AV, Caballero S, Aoki AM, Pinna LA, Grant MB, Castellon R (2004) Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization. Invest Ophthalmol Vis Sci 45:4583-4591. doi: 10.1167/ iovs.04-0686
3. Ficarro SB, McCleland ML, Stukenberg PT, Burke DJ, Ross MM, Shabanowitz J et al (2002) Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat Biotechnol 20:301-305. doi: 10.1038/nbt0302-301
4. Landesman-Bollag E, Song DH, Romieu-Mourez R, Sussman DJ, Cardiff RD, Sonenshein GE et al (2001) Protein kinase CK2: Signaling and tumorigenesis in the mammary gland. Mol Cell Biochem 227(1-2):153-165. doi: 10.1023/A:1013108822847
5. Zień P, Bretner M, Zasta̧piło K, Szyszka R, Shugar D (2003) Selectivity of 4, 5, 6, 7-tetrabromobenzimidazole as an ATP-competitive potent inhibitor of protein kinase CK2 from various sources. Biochem Biophys Res Commun 306:129-133. doi: 10.1016/ S0006-291X(03)00928-8
6. Pagano MA, Andrzejewska M, Ruzzene M, Sarno S, Cesaro L, Bain J et al (2004) Optimization of protein kinase CK2 inhibitors derived from 4, 5, 6, 7-tetrabromobenzimidazole. J Med Chem 47:6239-6247. doi: 10.1021/ jm049854a
7. Sarno S, Reddy H, Meggio F, Ruzzene M, Davies SP, Donella-Deana A et al (2001) Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 (casein kinase-2). FEBS Lett 496:44-48. doi: 10.1016/S0014-5793(01)02404-8
8. Battistutta R, Mazzorana M, Cendron L, Bortolato A, Sarno S, Kazimierczuk Z et al (2007) The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules. ChemBioChem 8(15):1804-1809. doi: 10.1002/cbic.200700307
9. Zień P, Duncan JS, Skierski J, Bretner M, Litchfield DW, Shugar D (2005) Tetrabromobenzotriazole (TBBt) and tetrabromobenzimidazole (TBBz) as selective inhibitors of protein kinase CK2: Evaluation of their effects on cells and different molecular forms of human CK2. Biochim Biophys Acta 1754:271-280
10. Mishra S, Pertz V, Zhang B, Kaur P, Shimada H, Groffen J et al (2007) Treatment of P190 Bcr/Abl lymphoblastic leukemia cells with inhibitors of the serine/threonine kinase CK2. Leukemia 21(1):178-180. doi: 10.1038/ sj.leu.2404460
11. Grankowski N, Boldyreff B, Issinger OG (1991) Isolation and characterization of recombinant human casein kinase II subunits alpha and beta from bacteria. Eur J Biochem 198:25-30. doi: 10.1111/ j.1432-1033.1991.tb15982.x
12. Sarno S, Vaglio P, Meggio F, Issinger OG, Pinna LA (1996) Protein kinase CK2 mutants defective in substrate recognition. Purification and kinetic analysis. J Biol Chem 271:10595-10601. doi: 10.1074/jbc.271.18.10595
13. Bretner M, Baier A, Kopańska K, Najda A, Schoof A, Reinholz M et al (2005) Synthesis and biological activity of 1H-benzotriazole and 1H-benzimidazole analogues - inhibitors of the NTpase/helicase of HCV and of some related Flaviviridae. Antivir Chem Chemother 16(5):315-326
14. Bretner M, Zień P, Najda A, Kulikowski T, Shugar D (2006) Patent Application P 380112